Furthermore, we assumed that Tlr4-/- mice responding to TAC with reduced cardiac hypertrophy and inflammation are protected from a LTA or CpG-ODN induced hyperinflammatory cardiac response. The gene discussed is TLR4; the disease is cardiac hypertrophy.